Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1300 entries
Sorted by: Best Match Show Resources per page
MRI characteristics of primary fallopian tube choriocarcinoma: a case report.

Radiology case reports

Jia HR, Zhang J, Guo YM.
PMID: 28491175
Radiol Case Rep. 2017 Mar 06;12(2):300-303. doi: 10.1016/j.radcr.2017.01.015. eCollection 2017 Jun.

Tubal choriocarcinoma is uncommon, and its magnetic resonance imaging characteristics have not yet been reported. In this report, a 39-year-old woman presented with irregular painless vaginal bleeding and a palpable left lower abdominal lump for 2 months following 6...

Cite
Jia HR, Zhang J, Guo YM. MRI characteristics of primary fallopian tube choriocarcinoma: a case report. Radiol Case Rep. 2017;12(2):300-303doi: 10.1016/j.radcr.2017.01.015.
Jia, H. R., Zhang, J., & Guo, Y. M. (2017). MRI characteristics of primary fallopian tube choriocarcinoma: a case report. Radiology case reports, 12(2), 300-303. https://doi.org/10.1016/j.radcr.2017.01.015
Jia, Hui-Ru, et al. "MRI characteristics of primary fallopian tube choriocarcinoma: a case report." Radiology case reports vol. 12,2 (2017): 300-303. doi: https://doi.org/10.1016/j.radcr.2017.01.015
Jia HR, Zhang J, Guo YM. MRI characteristics of primary fallopian tube choriocarcinoma: a case report. Radiol Case Rep. 2017 Mar 06;12(2):300-303. doi: 10.1016/j.radcr.2017.01.015. eCollection 2017 Jun. PMID: 28491175; PMCID: PMC5417728.
Copy Download .nbib Format: NLM
Successful Outcome of Twin Gestation with Partial Mole and Co-Existing Live Fetus: A Case Report.

Journal of clinical and diagnostic research : JCDR

Rathod S, Rani R, John LB, Samal SK.
PMID: 26436001
J Clin Diagn Res. 2015 Aug;9(8):QD01-2. doi: 10.7860/JCDR/2015/13038.6268. Epub 2015 Aug 01.

Sad fetus syndrome comprising of a live twin gestation with a hydatidiform mole is a rare entity. The condition is even rarer when the co-existing live fetus is associated with a partial mole than a complete mole. We report...

Cite
Rathod S, Rani R, John LB, et al. Successful Outcome of Twin Gestation with Partial Mole and Co-Existing Live Fetus: A Case Report. J Clin Diagn Res. 2015;9(8):QD01-2doi: 10.7860/JCDR/2015/13038.6268.
Rathod, S., Rani, R., John, L. B., & Samal, S. K. (2015). Successful Outcome of Twin Gestation with Partial Mole and Co-Existing Live Fetus: A Case Report. Journal of clinical and diagnostic research : JCDR, 9(8), QD01-2. https://doi.org/10.7860/JCDR/2015/13038.6268
Rathod, Setu, et al. "Successful Outcome of Twin Gestation with Partial Mole and Co-Existing Live Fetus: A Case Report." Journal of clinical and diagnostic research : JCDR vol. 9,8 (2015): QD01-2. doi: https://doi.org/10.7860/JCDR/2015/13038.6268
Rathod S, Rani R, John LB, Samal SK. Successful Outcome of Twin Gestation with Partial Mole and Co-Existing Live Fetus: A Case Report. J Clin Diagn Res. 2015 Aug;9(8):QD01-2. doi: 10.7860/JCDR/2015/13038.6268. Epub 2015 Aug 01. PMID: 26436001; PMCID: PMC4576594.
Copy Download .nbib Format: NLM
Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.

Frontiers in endocrinology

Younis JS.
PMID: 29051746
Front Endocrinol (Lausanne). 2017 Oct 05;8:264. doi: 10.3389/fendo.2017.00264. eCollection 2017.

No abstract available.

Cite
Younis JS. Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis. Front Endocrinol (Lausanne). 2017;8:264doi: 10.3389/fendo.2017.00264.
Younis, J. S. (2017). Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis. Frontiers in endocrinology, 8264. https://doi.org/10.3389/fendo.2017.00264
Younis, Johnny S. "Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis." Frontiers in endocrinology vol. 8 (2017): 264. doi: https://doi.org/10.3389/fendo.2017.00264
Younis JS. Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis. Front Endocrinol (Lausanne). 2017 Oct 05;8:264. doi: 10.3389/fendo.2017.00264. eCollection 2017. PMID: 29051746; PMCID: PMC5633777.
Copy Download .nbib Format: NLM
Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice.

Advanced biomedical research

Rashidi B, Mardani M, Karizbodagh MP.
PMID: 28989909
Adv Biomed Res. 2017 Sep 21;6:116. doi: 10.4103/abr.abr_179_16. eCollection 2017.

BACKGROUND: Human endometrium is a dynamic tissue during the menstrual cycle can be influenced by ovarian hormones. The purpose of this study was to evaluate the endometrium angiogenesis under the influence of human menopausal gonadotropin and human chorionic gonadotropin...

Cite
Rashidi B, Mardani M, Karizbodagh MP. Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice. Adv Biomed Res. 2017;6:116doi: 10.4103/abr.abr_179_16.
Rashidi, B., Mardani, M., & Karizbodagh, M. P. (2017). Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice. Advanced biomedical research, 6116. https://doi.org/10.4103/abr.abr_179_16
Rashidi, Bahman, et al. "Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice." Advanced biomedical research vol. 6 (2017): 116. doi: https://doi.org/10.4103/abr.abr_179_16
Rashidi B, Mardani M, Karizbodagh MP. Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice. Adv Biomed Res. 2017 Sep 21;6:116. doi: 10.4103/abr.abr_179_16. eCollection 2017. PMID: 28989909; PMCID: PMC5627566.
Copy Download .nbib Format: NLM
Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies.

Biomedical reports

Ren F, Hu YU, Zhou H, Zhu WY, Jia LI, Xu JJ, Xue J.
PMID: 27073636
Biomed Rep. 2016 Apr;4(4):475-478. doi: 10.3892/br.2016.611. Epub 2016 Feb 24.

The aim of the present study was to evaluate the serum levels of α-fetoprotein (AFP), free-β-human chorionic gonadotropin (free-β-hCG) and unconjugated estriol (uE

Cite
Ren F, Hu YU, Zhou H, et al. Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies. Biomed Rep. 2016;4(4):475-478doi: 10.3892/br.2016.611.
Ren, F., Hu, Y. U., Zhou, H., Zhu, W. Y., Jia, L. I., Xu, J. J., & Xue, J. (2016). Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies. Biomedical reports, 4(4), 475-478. https://doi.org/10.3892/br.2016.611
Ren, Feng, et al. "Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies." Biomedical reports vol. 4,4 (2016): 475-478. doi: https://doi.org/10.3892/br.2016.611
Ren F, Hu YU, Zhou H, Zhu WY, Jia LI, Xu JJ, Xue J. Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies. Biomed Rep. 2016 Apr;4(4):475-478. doi: 10.3892/br.2016.611. Epub 2016 Feb 24. PMID: 27073636; PMCID: PMC4812093.
Copy Download .nbib Format: NLM
Three histologically distinct cancers of the uterine corpus: A case report and review of the literature.

Molecular and clinical oncology

Masuyama H, Haraga J, Nishida T, Ogawa C, Kusumoto T, Nakamura K, Seki N, Yanai H, Hiramatsu Y.
PMID: 27073663
Mol Clin Oncol. 2016 Apr;4(4):563-566. doi: 10.3892/mco.2016.770. Epub 2016 Feb 05.

Collision tumors, which are characterized by the coexistence of two or more completely distinct and independent tumors in the uterine corpus, are very rare. A collision tumor is mainly composed of two distinct tumor types, epithelial and mesenchymal. To...

Cite
Masuyama H, Haraga J, Nishida T, et al. Three histologically distinct cancers of the uterine corpus: A case report and review of the literature. Mol Clin Oncol. 2016;4(4):563-566doi: 10.3892/mco.2016.770.
Masuyama, H., Haraga, J., Nishida, T., Ogawa, C., Kusumoto, T., Nakamura, K., Seki, N., Yanai, H., & Hiramatsu, Y. (2016). Three histologically distinct cancers of the uterine corpus: A case report and review of the literature. Molecular and clinical oncology, 4(4), 563-566. https://doi.org/10.3892/mco.2016.770
Masuyama, Hisashi, et al. "Three histologically distinct cancers of the uterine corpus: A case report and review of the literature." Molecular and clinical oncology vol. 4,4 (2016): 563-566. doi: https://doi.org/10.3892/mco.2016.770
Masuyama H, Haraga J, Nishida T, Ogawa C, Kusumoto T, Nakamura K, Seki N, Yanai H, Hiramatsu Y. Three histologically distinct cancers of the uterine corpus: A case report and review of the literature. Mol Clin Oncol. 2016 Apr;4(4):563-566. doi: 10.3892/mco.2016.770. Epub 2016 Feb 05. PMID: 27073663; PMCID: PMC4812600.
Copy Download .nbib Format: NLM
GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus.

Rambam Maimonides medical journal

Kol S, Fainaru O.
PMID: 28467768
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10300.

Final oocyte maturation is a crucial step in in vitro fertilization, traditionally achieved with a single bolus of human chorionic gonadotropin (hCG) given 36 hours before oocyte retrieval. This bolus exposes the patient to the risks of ovarian hyperstimulation...

Cite
Kol S, Fainaru O. GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus. Rambam Maimonides Med J. 2017;8(2)doi: 10.5041/RMMJ.10300.
Kol, S., & Fainaru, O. (2017). GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus. Rambam Maimonides medical journal, 8(2), . https://doi.org/10.5041/RMMJ.10300
Kol, Shahar, and Fainaru, Ofer. "GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus." Rambam Maimonides medical journal vol. 8,2 (2017). doi: https://doi.org/10.5041/RMMJ.10300
Kol S, Fainaru O. GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus. Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10300. PMID: 28467768; PMCID: PMC5415369.
Copy Download .nbib Format: NLM
Tumor necrosis factor alpha inhibits ovulation and induces granulosa cell death in rat ovaries.

Reproductive medicine and biology

Yamamoto Y, Kuwahara A, Taniguchi Y, Yamasaki M, Tanaka Y, Mukai Y, Yamashita M, Matsuzaki T, Yasui T, Irahara M.
PMID: 26161038
Reprod Med Biol. 2015;14(3):107-115. doi: 10.1007/s12522-014-0201-5. Epub 2014 Dec 13.

PURPOSE: We evaluated the role of tumor necrosis factor alpha (TNFα) in rat ovulation and granulosa cell death of ovarian follicles during the periovulatory stage.METHODS: Immature rats primed with pregnant mare serum gonadotropin were injected intraperitoneally with human chorionic...

Cite
Yamamoto Y, Kuwahara A, Taniguchi Y, et al. Tumor necrosis factor alpha inhibits ovulation and induces granulosa cell death in rat ovaries. Reprod Med Biol. 2014;14(3):107-115doi: 10.1007/s12522-014-0201-5.
Yamamoto, Y., Kuwahara, A., Taniguchi, Y., Yamasaki, M., Tanaka, Y., Mukai, Y., Yamashita, M., Matsuzaki, T., Yasui, T., & Irahara, M. (2015). Tumor necrosis factor alpha inhibits ovulation and induces granulosa cell death in rat ovaries. Reproductive medicine and biology, 14(3), 107-115. https://doi.org/10.1007/s12522-014-0201-5
Yamamoto, Yuri, et al. "Tumor necrosis factor alpha inhibits ovulation and induces granulosa cell death in rat ovaries." Reproductive medicine and biology vol. 14,3 (2015): 107-115. doi: https://doi.org/10.1007/s12522-014-0201-5
Yamamoto Y, Kuwahara A, Taniguchi Y, Yamasaki M, Tanaka Y, Mukai Y, Yamashita M, Matsuzaki T, Yasui T, Irahara M. Tumor necrosis factor alpha inhibits ovulation and induces granulosa cell death in rat ovaries. Reprod Med Biol. 2015;14(3):107-115. doi: 10.1007/s12522-014-0201-5. Epub 2014 Dec 13. PMID: 26161038; PMCID: PMC4490172.
Copy Download .nbib Format: NLM
An invasive mole with bilateral kidney metastases: A case report.

Oncology letters

Yao K, Gan YU, Tang Y, Tang J, He L, Dai Y.
PMID: 26788142
Oncol Lett. 2015 Dec;10(6):3407-3410. doi: 10.3892/ol.2015.3768. Epub 2015 Sep 29.

Clinical reports of kidney metastases derived from an invasive mole (IM) are rare. The present study presents the case of a 42-year-old woman who exhibited IM and bilateral kidneys metastases in what may be, to the best of our...

Cite
Yao K, Gan YU, Tang Y, et al. An invasive mole with bilateral kidney metastases: A case report. Oncol Lett. 2015;10(6):3407-3410doi: 10.3892/ol.2015.3768.
Yao, K., Gan, Y. U., Tang, Y., Tang, J., He, L., & Dai, Y. (2015). An invasive mole with bilateral kidney metastases: A case report. Oncology letters, 10(6), 3407-3410. https://doi.org/10.3892/ol.2015.3768
Yao, Kun, et al. "An invasive mole with bilateral kidney metastases: A case report." Oncology letters vol. 10,6 (2015): 3407-3410. doi: https://doi.org/10.3892/ol.2015.3768
Yao K, Gan YU, Tang Y, Tang J, He L, Dai Y. An invasive mole with bilateral kidney metastases: A case report. Oncol Lett. 2015 Dec;10(6):3407-3410. doi: 10.3892/ol.2015.3768. Epub 2015 Sep 29. PMID: 26788142; PMCID: PMC4665133.
Copy Download .nbib Format: NLM
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study.

Journal of human reproductive sciences

Mahajan N, Sharma S, Arora PR, Gupta S, Rani K, Naidu P.
PMID: 27382235
J Hum Reprod Sci. 2016 Apr-Jun;9(2):101-6. doi: 10.4103/0974-1208.183506.

BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte...

Cite
Mahajan N, Sharma S, Arora PR, et al. Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study. J Hum Reprod Sci. 2016;9(2):101-6doi: 10.4103/0974-1208.183506.
Mahajan, N., Sharma, S., Arora, P. R., Gupta, S., Rani, K., & Naidu, P. (2016). Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study. Journal of human reproductive sciences, 9(2), 101-6. https://doi.org/10.4103/0974-1208.183506
Mahajan, Nalini, et al. "Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study." Journal of human reproductive sciences vol. 9,2 (2016): 101-6. doi: https://doi.org/10.4103/0974-1208.183506
Mahajan N, Sharma S, Arora PR, Gupta S, Rani K, Naidu P. Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study. J Hum Reprod Sci. 2016 Apr-Jun;9(2):101-6. doi: 10.4103/0974-1208.183506. PMID: 27382235; PMCID: PMC4915279.
Copy Download .nbib Format: NLM
Placenta Percreta Presenting with Delayed Haematuria.

Journal of clinical and diagnostic research : JCDR

Wagaskar VG, Daga SO, Patwardhan SK.
PMID: 26816944
J Clin Diagn Res. 2015 Dec;9(12):PD01-2. doi: 10.7860/JCDR/2015/16411.6935. Epub 2015 Dec 01.

Placenta percreta presents as life threatening complications with bladder invasion. A condition of placenta invading urinary bladder presented with differential diagnosis of gestational trophoblastic neoplasia on imaging and responded to chemotherapy. A 35-year-old primi-gravida presented at term with per...

Cite
Wagaskar VG, Daga SO, Patwardhan SK. Placenta Percreta Presenting with Delayed Haematuria. J Clin Diagn Res. 2015;9(12):PD01-2doi: 10.7860/JCDR/2015/16411.6935.
Wagaskar, V. G., Daga, S. O., & Patwardhan, S. K. (2015). Placenta Percreta Presenting with Delayed Haematuria. Journal of clinical and diagnostic research : JCDR, 9(12), PD01-2. https://doi.org/10.7860/JCDR/2015/16411.6935
Wagaskar, Vinayak Gorakhanath, et al. "Placenta Percreta Presenting with Delayed Haematuria." Journal of clinical and diagnostic research : JCDR vol. 9,12 (2015): PD01-2. doi: https://doi.org/10.7860/JCDR/2015/16411.6935
Wagaskar VG, Daga SO, Patwardhan SK. Placenta Percreta Presenting with Delayed Haematuria. J Clin Diagn Res. 2015 Dec;9(12):PD01-2. doi: 10.7860/JCDR/2015/16411.6935. Epub 2015 Dec 01. PMID: 26816944; PMCID: PMC4717779.
Copy Download .nbib Format: NLM
Plasma progesterone profile and conception rate following exogenous supplementation of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone releasing intra-vaginal device in repeat-breeder crossbred cows.

Veterinary world

Pandey NK, Gupta HP, Prasad S, Sheetal SK.
PMID: 27397976
Vet World. 2016 Jun;9(6):559-62. doi: 10.14202/vetworld.2016.559-562. Epub 2016 Jun 05.

AIM: This study was designed to evaluate the effect of gonadotropin-releasing hormone (GnRH), human chorionic gonadotropin (hCG), and progesterone impregnated intra-vaginal device on progesterone profile and conception rate in repeat-breeding crossbred cows.MATERIALS AND METHODS: Repeat-breeding crossbred cows aged 3-8...

Cite
Pandey NK, Gupta HP, Prasad S, et al. Plasma progesterone profile and conception rate following exogenous supplementation of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone releasing intra-vaginal device in repeat-breeder crossbred cows. Vet World. 2016;9(6):559-62doi: 10.14202/vetworld.2016.559-562.
Pandey, N. K., Gupta, H. P., Prasad, S., & Sheetal, S. K. (2016). Plasma progesterone profile and conception rate following exogenous supplementation of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone releasing intra-vaginal device in repeat-breeder crossbred cows. Veterinary world, 9(6), 559-62. https://doi.org/10.14202/vetworld.2016.559-562
Pandey, N K J, et al. "Plasma progesterone profile and conception rate following exogenous supplementation of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone releasing intra-vaginal device in repeat-breeder crossbred cows." Veterinary world vol. 9,6 (2016): 559-62. doi: https://doi.org/10.14202/vetworld.2016.559-562
Pandey NK, Gupta HP, Prasad S, Sheetal SK. Plasma progesterone profile and conception rate following exogenous supplementation of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone releasing intra-vaginal device in repeat-breeder crossbred cows. Vet World. 2016 Jun;9(6):559-62. doi: 10.14202/vetworld.2016.559-562. Epub 2016 Jun 05. PMID: 27397976; PMCID: PMC4937044.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1300 entries